Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue Outset Medical Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue AZZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency GEGGL Q1 2026 Earnings Significant EPS Miss with No Revenue Reported WSFS Q1 2026 Earnings Strong EPS Beat Driven by Core Banking Strength